Evidence map›Paper›PMID 29230136›Full record

ArticleGastroenterology & hepatology2017

Managing the Adult Patient With Short Bowel Syndrome.

Carol Rees Parrish, John K DiBaise

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Gastroenterology & hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06904872 (A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study of 2 Doses of Crofelemer for the Treatment of Adult Patients With Short Bowel Syndrome and Intestinal Failure), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06904872 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study of 2 Doses of Crofelemer for the Treatment of Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

TypeinterventionalSponsorNapo Therapeutics, S.p.A.Ran2025 to 2027Enrolled18ConditionsShort Bowel Syndrome, Malabsorption Syndromes, Short Gut Syndrome, Post-Op ComplicationArmsCrofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Quality of life and healthcare resource utilization among adult patients with short bowel syndrome: A mixed-methods study leveraging an integrated database.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Fat malabsorption in short bowel syndrome: A review of pathophysiology and management.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2024
    Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Fecal microbiome and bile acid metabolome in adult short bowel syndrome.American journal of physiology. Gastrointestinal and liver physiology · 2022
    Article
  15. Article
  16. Acute Intestinal Failure.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Review
  17. Article
  18. Article
  19. A rodent model of partial intestinal diversion: a novel metabolic operation.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carol Rees ParrishMs Parrish is a nutrition support specialist at the University of Virginia Health System's Digestive Health Center in Charlottesville, Virginia. Dr DiBaise is a professor of medicine in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Scottsdale, Arizona.
John K DiBaiseMs Parrish is a nutrition support specialist at the University of Virginia Health System's Digestive Health Center in Charlottesville, Virginia. Dr DiBaise is a professor of medicine in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Scottsdale, Arizona.
Mayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short bowel syndrome (SBS) is a malabsorptive disorder associated with significant morbidity and mortality, reduced quality of life, and high health care costs. Managing the patient with SBS requires an understanding of gastrointestinal anatomy and physiology; a dedicated multidisciplinary team; and the coordination of dietary, fluid, pharmacologic, and comorbid disease management. This article provides an overview of the current state of management of SBS, including a practical approach to optimizing the care and quality of life of the adult patient with SBS.

Indexed as

intestinal failuremanagementmultidisciplinaryShort bowel syndrome

Identifiers

PMID29230136
PMCPMC5718176
OpenAlexW2777371859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.